BL 1827
Alternative Names: Analgesic sublingual spray - Bioglan Pharma/CeNeS Pharmaceuticals; Opioid sublingual aerosol sprayLatest Information Update: 12 Aug 2002
At a glance
- Originator Bioglan Pharma [CEASED]
- Class Analgesics
- Mechanism of Action Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer pain; Postoperative pain
Most Recent Events
- 12 Aug 2002 The agent is available for licensing (www.cenes.uk.com)
- 12 Aug 2002 Discontinued - Phase-I for Cancer pain in United Kingdom (Sublingual)
- 12 Aug 2002 Discontinued - Phase-I for Postoperative pain in United Kingdom (Sublingual)